Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity.

Kang CH, Tsai CM, Wu TH, Wu HY, Chung MY, Chen CC, Huang YC, Liu SF, Liao DL, Niu CK, Lee CH, Yu HR.

Pediatr Pulmonol. 2014 Apr;49(4):381-8. doi: 10.1002/ppul.22750. Epub 2013 Jan 28.

PMID:
23359527
2.

Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.

Lin CC, Liu TC, Kuo CF, Liu CP, Lee CM.

J Microbiol Immunol Infect. 2010 Aug;43(4):323-31. doi: 10.1016/S1684-1182(10)60050-3.

3.

Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report.

Nakwan N, Wannaro J, Thongmak T, Pornladnum P, Saksawad R, Nakwan N, Chokephaibulkit K.

Pediatr Pulmonol. 2011 Jan;46(1):60-6. doi: 10.1002/ppul.21324. Epub 2010 Sep 1.

PMID:
20812247
4.

Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.

Celik IH, Oguz SS, Demirel G, Erdeve O, Dilmen U.

Eur J Pediatr. 2012 Feb;171(2):311-6. doi: 10.1007/s00431-011-1537-z. Epub 2011 Aug 2.

PMID:
21809011
5.

Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.

Arnold HM, Sawyer AM, Kollef MH.

Respir Care. 2012 Aug;57(8):1226-33. doi: 10.4187/respcare.01556. Epub 2012 Feb 17.

6.

Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.

Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME.

Respir Med. 2008 Mar;102(3):407-12. Epub 2007 Dec 3.

7.

Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Lu Q, Luo R, Bodin L, Yang J, Zahr N, Aubry A, Golmard JL, Rouby JJ; Nebulized Antibiotics Study Group.

Anesthesiology. 2012 Dec;117(6):1335-47. doi: 10.1097/ALN.0b013e31827515de.

PMID:
23132092
8.

Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?

Kalin G, Alp E, Coskun R, Demiraslan H, Gündogan K, Doganay M.

J Infect Chemother. 2012 Dec;18(6):872-7. doi: 10.1007/s10156-012-0430-7. Epub 2012 May 29.

PMID:
22644081
9.

Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.

Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A.

Respir Med. 2009 May;103(5):707-13. doi: 10.1016/j.rmed.2008.11.018. Epub 2008 Dec 31.

10.

Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?

Demirdal T, Sari US, Nemli SA.

Ann Clin Microbiol Antimicrob. 2016 Feb 24;15:11. doi: 10.1186/s12941-016-0123-7.

11.

Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.

Kofteridis DP, Alexopoulou C, Valachis A, Maraki S, Dimopoulou D, Georgopoulos D, Samonis G.

Clin Infect Dis. 2010 Dec 1;51(11):1238-44. doi: 10.1086/657242. Epub 2010 Oct 25.

PMID:
20973727
12.

Impact of colistin-initiation delay on mortality of ventilator-associated pneumonia caused by A. baumannii.

Samrah S, Bashtawi Y, Hayajneh W, Almomani B, Momany S, Khader Y.

J Infect Dev Ctries. 2016 Oct 31;10(10):1129-1134. doi: 10.3855/jidc.7203.

13.

Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Aydemir H, Akduman D, Piskin N, Comert F, Horuz E, Terzi A, Kokturk F, Ornek T, Celebi G.

Epidemiol Infect. 2013 Jun;141(6):1214-22. doi: 10.1017/S095026881200194X. Epub 2012 Sep 7.

PMID:
22954403
14.

Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.

Khawcharoenporn T, Pruetpongpun N, Tiamsak P, Rutchanawech S, Mundy LM, Apisarnthanarak A.

Int J Antimicrob Agents. 2014 Apr;43(4):378-82. doi: 10.1016/j.ijantimicag.2014.01.016. Epub 2014 Feb 14.

PMID:
24613422
15.

[Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].

Taşbakan MS, Pullukçu H, Ekren PK, Oz AT, Midilli M, Aydemir S, Gürgün A, Başoğlu OK, Bacakoğlu F.

Mikrobiyol Bul. 2009 Jan;43(1):61-70. Turkish.

PMID:
19334381
16.

Inhaled colistin for treatment of pneumonia due to colistin-only-susceptible Acinetobacter baumannii.

Choi HK, Kim YK, Kim HY, Uh Y.

Yonsei Med J. 2014 Jan;55(1):118-25. doi: 10.3349/ymj.2014.55.1.118.

17.

Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.

Inchai J, Liwsrisakun C, Theerakittikul T, Chaiwarith R, Khositsakulchai W, Pothirat C.

J Infect Chemother. 2015 Aug;21(8):570-4. doi: 10.1016/j.jiac.2015.04.010. Epub 2015 May 7.

PMID:
26026660
18.

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.

Betrosian AP, Frantzeskaki F, Xanthaki A, Douzinas EE.

J Infect. 2008 Jun;56(6):432-6. doi: 10.1016/j.jinf.2008.04.002. Epub 2008 May 23.

PMID:
18501431
19.

Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.

Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA.

Pediatr Pulmonol. 2010 Nov;45(11):1135-40. doi: 10.1002/ppul.21302.

PMID:
20658485
20.

Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia.

Czosnowski QA, Wood GC, Magnotti LJ, Croce MA, Swanson JM, Boucher BA, Fabian TC.

Pharmacotherapy. 2009 Sep;29(9):1054-60. doi: 10.1592/phco.29.9.1054.

PMID:
19698010

Supplemental Content

Support Center